title: Comparative effectiveness research in the USA: when will there be an impact on healthcare decision-making?
abstract: Five annual surveys of healthcare decision-makers potentially affected by comparative effectiveness research (CER) indicate sustained recognition of its importance and potential impact. Initial expectations of immediate CER impact have over time turned to stakeholder assessments of little short-term impact. In successive surveys, they project a continuous horizon of 3-5 years for CER to have a moderate or substantial improvement in decision making. The prominence of Patient-Centered Outcomes Research Institute in CER is highlighted by stakeholders, but greater emphasis on translating and disseminating research findings is needed, a role in which Agency for Healthcare Research and Quality is expected to contribute. Stakeholders, including patients, must be engaged throughout to ensure that findings provide the flexibility for decision makers to apply them to their patient populations.
authors.affiliation: National Pharmaceutical Council, 1717 Pennsylvania Avenue, NW Washington, DC 20006, USA.
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Westrich
authors.affiliation: Social & Scientific Systems, 8757 Georgia Avenue, Silver Spring, MD 20910, USA.
authors.forename: Jess A
authors.initials: JA
authors.lastname: Wilhelm
authors.affiliation: Social & Scientific Systems, 8757 Georgia Avenue, Silver Spring, MD 20910, USA.
authors.forename: Claudia L
authors.initials: CL
authors.lastname: Schur
keywords: comparative effectiveness research; health policy; outcomes research